Join        Login             Stock Quote

Radius Health Sets IPO Pricing Between $8.50 And $10.50

 October 22, 2012 09:55 AM

Radius Health Inc., a developer of therapies for osteoporosis and women's health, has set the terms for its initial public offering (IPO).

The Cambridge, Massachusetts-based company has launched an IPO of 6.5 million shares, with an estimated pricing between $8.50 and $10.50 apiece.

At the midpoint of the proposed range, Radius Health's will have an initial market capitalization of roughly $283 million. The company expects net proceeds from the offering to be roughly $55.8 million.

Radius has raised a total of $172.5 million from the following investors including:MPM Capital, HealthCare Ventures LLC, Brookside Capital and Oxford Bioscience Partners.

The company expect to use the net proceeds to fund the clinical development of its most advanced product candidates and for other general corporate purposes.

[Related -Is The Slump In US Manufacturing Easing?]

Radius Health's only product candidates are BA058, RAD1901 and RAD140, and none of these product candidates is approved by the FDA for sale, the company said in a regulatory filing.

For the 12 months ended December 2011, Radius Health posted a net loss of $42.5 million.

The company plans to list on the Nasdaq under the symbol "RDUS".

Radius Health has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares to cover over-allotments.

UBS and Leerink Swann will be serving as co-lead underwriters.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Related Articles:

It's Never Too Late To Build An Income Portfolio
More Articles on: Medical

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.